Vir Biotechnology, Inc. (VIR)

Import this data to Google Sheets with:

=jivedata("VIR","financials")

Full statements spill as a table. For one cell: =jivedata("VIR","Revenue") or =jivedata("VIR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Vir Biotechnology, Inc.

VIR • CIK 0001706431

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-684,305	$-587,165	$-479,328	$-280,187
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-628,194	$-523,105	$-437,770	$-251,299
Income Tax Expense (Benefit)	$-13,077	$-1,145	$217	$380
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-615,117	$-521,960	$-437,987	$-437,987
Net Income (Loss) Attributable to Noncontrolling Interest	—	$0	$0	$0
Weighted Average Number of Shares Outstanding, Basic	134,130,924	136,246,865	138,520,419	158,173,109
Revenues	$86,180	$74,205	$68,556	$303,227
Cost of Revenue	$2,765	$845	$26	$15
Research and Development Expense	$589,671	$506,499	$455,966	$484,017
Selling, General and Administrative Expense	$178,049	$119,031	$92,074	$99,382
Restructuring Costs and Asset Impairment Charges	—	$34,995	$-182	$0
Costs and Expenses	$770,485	$661,370	$547,884	$583,414
Equity Securities, FV-NI, Unrealized Gain (Loss)	$-21,888	$-5,528	$1,729	$-3,164
Investment Income, Interest	—	$71,809	$40,238	$33,320
Other Nonoperating Income (Expense)	$-8,991	$-2,221	$-409	$-1,268
Nonoperating Income (Expense)	$56,111	$64,060	$41,558	$28,888

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$241,576	$222,947	$232,185	$278,729
Marketable Securities, Current	$1,270,980	$678,051	$228,753	$249,864
Intangible Assets, Net (Excluding Goodwill)	$22,565	$8,120	$7,850	$7,702
Restricted Cash and Cash Equivalents, Current	$13,268	$89,385	$1,922	$1,929
Goodwill	$16,937	$16,937	$16,937	$16,937
Equity Securities, FV-NI	—	$4,350	$6,077	$4,133
Property, Plant and Equipment, Net	$96,018	$63,183	$55,620	$50,430
Prepaid Expense and Other Assets, Current	$52,549	$47,725	$45,143	$39,084
Operating Lease, Right-of-Use Asset	$71,182	$59,680	$62,099	$59,391
Assets, Current	$1,588,226	$1,042,458	$514,080	$573,739
Restricted Cash and Cash Equivalents, Noncurrent	$6,448	$6,363	$6,963	$6,944
Long-term Investments	$105,275	$190,015	$314,575	$475,016
Other Assets	$12,409	$12,057	$24,699	$24,647
Assets	$1,919,060	$1,398,813	$1,002,823	$1,214,806
Operating Lease, Liability, Noncurrent	$111,673	$90,139	$89,054	$84,137
Business Combination, Contingent Consideration, Liability, Noncurrent	$25,960	$24,050	$34,100	$34,340
Other Liabilities, Noncurrent	$14,258	$14,577	$21,578	$18,875
Liabilities	$328,824	$248,428	$237,547	$232,313
Accounts Payable, Current	$6,334	$5,081	$9,803	$17,754
Accrued Liabilities and Other Liabilities	$104,220	$85,873	$83,012	$77,207
Business Combination, Contingent Consideration, Liability, Current	—	$16,060	$0	$0
Liabilities, Current	$175,407	$119,662	$92,815	$94,961
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$13	$14	$14	$17
Additional Paid in Capital	$1,828,862	$1,911,872	$1,965,090	$2,230,464
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-815	$-1,717	$-2,057	$-4,602
Retained Earnings (Accumulated Deficit)	$-237,824	$-759,784	$-1,197,771	$-1,243,386
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$1,590,236	$1,150,385	$765,276	$982,493
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	300,000,000	300,000,000	300,000,000	300,000,000
Common Stock, Shares, Issued	134,781,286	136,959,446	139,474,954	169,185,671
Depreciation	—	$14,200	$11,400	$5,400
Property, Plant and Equipment, Gross	$129,914	$99,968	$102,780	$103,055
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$33,896	$36,785	$47,160	$52,625
Operating Lease, Liability, Current	$12,867	$7,752	$8,798	$9,137
Accrued Professional Fees, Current	$3,418	$2,268	$3,327	$9,009
Contract with Customer, Liability, Current	—	—	$0	$0
Other Accrued Liabilities, Current	$3,317	$3,874	$5,039	$7,807
Operating Lease, Liability	$124,540	$97,891	$97,852	$97,852

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-615,117	$-521,960	$-437,987	$-437,987
Net Cash Provided by (Used in) Operating Activities	$-778,785	$-446,352	$-391,781	$-202,506
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-606,676	$57,403	$-77,625	$-18,676
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$261,292	$318,695	$241,070	$156,117
Depreciation, Depletion and Amortization	$18,920	$14,559	$11,680	$11,509
Proceeds from Sale of Machinery and Equipment	—	—	$253	$-73
Accretion (Amortization) of Discounts and Premiums, Investments	$8,706	$-5,397	$-9,474	$-3,580
Payments to Acquire Property, Plant, and Equipment	$21,573	$7,301	$4,832	$1,087
Payments to Acquire Investments	$2,016,189	$1,235,339	$886,334	$1,030,742
Assets, Fair Value Adjustment	$21,888	$5,528	$-1,729	$3,164
Proceeds from Sale, Maturity and Collection of Investments	$2,202,391	$1,738,635	$1,201,284	$973,692
Net Cash Provided by (Used in) Investing Activities	$164,629	$499,367	$310,371	$-58,210
Share-based Payment Arrangement, Noncash Expense	$111,316	$78,457	$49,072	$47,040
Impairment of Intangible Assets (Excluding Goodwill)	—	$14,550	$0	$0
Proceeds from Stock Options Exercised	$3,484	$790	$1,349	$1,716
Proceeds from Stock Plans	$4,283	$3,763	$2,797	$2,396
Proceeds from (Payments for) Other Financing Activities	—	$-165	$-361	$-1
Net Cash Provided by (Used in) Financing Activities	$7,480	$4,388	$3,785	$242,040
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$957	—	$7,329	$-262
Cash and Cash Equivalents, at Carrying Value	$241,576	$222,947	$232,185	$232,775
Restricted Cash and Cash Equivalents, Current	$13,268	$89,385	$1,922	$-84,304
Restricted Cash and Cash Equivalents, Noncurrent	$6,448	$6,363	$6,963	$7,646
Increase (Decrease) in Prepaid Expense and Other Assets	$-64,970	$-10,186	$-2,075	$-2,197
Increase (Decrease) in Other Operating Assets	$-2,161	$-353	$12,642	$11,457
Increase (Decrease) in Accounts Payable	$732	$-988	$4,997	$5,636
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities	$-356,498	$-10,287	$-9,509	$-12,882
IncreaseDecreaseInOperatingLeaseLiability	$-13,046	$-23,027	$-7,368	$-8,694

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("VIR","financials")

Full statements spill as a table. For one cell: =jivedata("VIR","Revenue") or =jivedata("VIR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.